Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: March 2012
-
By Kevin E. Noonan — This week's edition of Nature contains the results of the latest (and last) of the "genome" projects for members of the Homini (humans and their closest primate ancestors): Gorilla gorilla gorilla, the western lowland gorilla (in particular a gorilla named Kamilah, the Craig Venter of her species) (Saclly et al.,…
-
By Donald Zuhn — Last month, the European Patent Office announced the launch of a new machine translation service, Patent Translate. Patent Translate, which uses Google Translate technology, allows users to translate between English and French, German, Spanish, Italian, Portuguese, or Swedish. The EPO press release on the launch noted that translations offered by the…
-
By Donald Zuhn — In February, the U.S. Patent and Trademark Office announced the establishment of the Thomas Alva Edison Visiting Professionals Program, which is designed to tap into the expertise of distinguished IP professionals and academics who are able to devote up to six months of service to the Office on a full time…
-
Federal Circuit Overrules PTO on Statutory Construction By Kevin E. Noonan — The interplay between the U.S. Patent and Trademark Office and its supervisory appellate court (whether the Court of Customs and Patent Appeals or, after 1982, the Federal Circuit) is of long vintage. Examples include the dispute between the CCPA (particularly Judge Rich) and…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Cephalon Inc. v. Mylan Pharmaceuticals Inc. et al.1:12-cv-00247; filed February 29, 2012 in the District Court of Delaware • Plaintiff: Cephalon Inc.• Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc. Cephalon Inc. v. Sandoz Inc.1:12-cv-00248; filed February…
-
March 6, 2012 – Biotechnology/Chemical/Pharmaceutical (BCP) Customer Partnership Meeting (U.S. Patent and Trademark Office) – 9:30 am – 4:00 pm (ET) March 14-15, 2012 – Biotech Patenting (C5) – Munich, Germany March 20-21, 2012 – FDA Boot Camp*** (American Conference Institute) – New York, NY March 26-27, 2012 – PTO Procedures under the America Invents…
-
McDonnell Boehnen Hulbert & Berghoff LLP will be offering a live webinar on the "The Biosimilar Drug Approval Pathway: Draft FDA Guidance and Beyond" on March 27, 2012 from 10:00 am to 11:15 am (CT). Patent Docs authors and MBHB attorneys Dr. Kevin Noonan and Dr. James DeGiulio will provide a detailed analysis of the…
-
Managing Intellectual Property will be holding the US Patent Reform Forum 2012 on March 27, 2012 in Washington, DC. The conference will offer presentations on: • Roundtable: AIA rulemaking overview;• An industry perspective: We lobbied the cause; the act was passed — where did we land?• Key considerations: The joinder provision; ITC proceedings and the…
-
D Young & Co. will be offering its next European biotech patent law update on April 18, 2012. The 45-minute webinar will be offered at two times: 7:00 am (EDT) and 12:00 pm (EDT). Robert Dempster and Simon O'Brien will provide an essential update and live Q&A on European biotechnology case law. While there is…
-
By Donald Zuhn — Last month, the U.S. Patent and Trademark Office, exercising the new fee setting authority conferred upon the Office by § 10 of the Leahy-Smith America Invents Act, submitted a table of patent fee changes to the Patent Public Advisory Committee (PPAC). The proposed fee changes were submitted to the PPAC in…
Patent Docs 